BIO-TECHNE CORP

19 February, 2025

Bio-Techne Reports Strong Q2 Performance with 9% Revenue Growth and Outperforms Earnings Estimates, Shares Rise 6%

Bio-Techne Corp (Symbol: TECH) has delivered impressive financial results for the fiscal second quarter of 2025, reporting revenues of $297 million, a 9% increase year-over-year that exceeded Wall Str...
Read More

13 February, 2025

Bio-Techne Stock Drops Over 5% Amid NIH Funding Cuts Concerns

Bio-Techne (TECH) has faced significant stock price declines recently, with a drop exceeding 5%, contributing to a downward trend in the lab-tool equipment sector. This decrease is primarily linked to...
Read More

12 February, 2025

Bio-Techne Stock Drops Over 5% Amid NIH Funding Cuts Concerns

Bio-Techne (TECH) has faced significant stock price declines recently, with a drop exceeding 5%, contributing to a downward trend in the lab-tool equipment sector. This decrease is primarily linked to...
Read More

11 February, 2025

Bio-Techne Stock Plummets Over 5% Amid NIH Funding Cuts for Medical Research

Bio-Techne (TECH) has been significantly impacted by recent policy adjustments from the National Institutes of Health (NIH), leading to a decline of over 5% in its stock value. This downturn occurs in...
Read More